These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Market watch: Sales of biologics to show robust growth through to 2013. Goodman M Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035 [No Abstract] [Full Text] [Related]
8. US policy may encourage counterfeit drugs. Bouchie A Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826 [No Abstract] [Full Text] [Related]
9. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1. Kuhrt K; Chace-Ortiz M IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217 [TBL] [Abstract][Full Text] [Related]
10. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
11. Follow-on biologics: data exclusivity and the balance between innovation and competition. Grabowski H Nat Rev Drug Discov; 2008 Jun; 7(6):479-88. PubMed ID: 18469828 [TBL] [Abstract][Full Text] [Related]
12. How Indian biotech is driving innovation. Nogrady B Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184 [No Abstract] [Full Text] [Related]
14. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law. Dinh TQ Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027 [No Abstract] [Full Text] [Related]
15. Balancing innovation, access, and profits--market exclusivity for biologics. Engelberg AB; Kesselheim AS; Avorn J N Engl J Med; 2009 Nov; 361(20):1917-9. PubMed ID: 19828525 [No Abstract] [Full Text] [Related]
16. Betting on biogenerics. Dove A Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723 [No Abstract] [Full Text] [Related]
17. Biotechs go generic: the same but different. Ledford H Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194 [No Abstract] [Full Text] [Related]
19. Data exclusivity for biologics. Grabowski H; Long G; Mortimer R Nat Rev Drug Discov; 2011 Jan; 10(1):15-6. PubMed ID: 21193860 [No Abstract] [Full Text] [Related]
20. The market for follow-on biologics: how will it evolve? Grabowski H; Cockburn I; Long G Health Aff (Millwood); 2006; 25(5):1291-301. PubMed ID: 16966725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]